跳至主要内容
临床试验/NCT01453452
NCT01453452已完成不适用

S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II

SWOG Cancer Research Network115 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
115
主要终点
Attendance of ≥ 2 Curves sessions/week for a minimum of 36 of the 52 weeks of intervention

研究概览

简要总结

RATIONALE: Physical activity, diet, and counseling may help breast and colorectal cancer survivors to lose weight and improve their quality of life.

PURPOSE: This phase II trial studies how well exercise, diet, and counseling work in improving physical activity and weight loss in overweight women who are breast and colorectal cancer survivors.

详细描述

OBJECTIVES:

Primary

  • To determine the feasibility of a 12-month community-based combined physical activity and dietary change weight-loss intervention in overweight and sedentary female breast and colorectal cancer survivors recruited via the Southwest Oncology Group (SWOG).
  • To estimate the effect size of the intervention on weight loss at 12 months.

Secondary

  • To measure changes in anthropometric measures from baseline (body mass index [BMI], waist and hip circumference) at 6 and 12 months and body composition (% body fat as assessed by dual-energy X-ray absorptiometry [DXA] scan) at 12 months.
  • To measure changes in minutes spent per week in moderate-to-vigorous aerobic activity from baseline using Curves attendance records and a 7-day physical activity assessment at 6 and 12 months.
  • To measure changes from baseline to 6 and 12 months in dietary intake of carotenoids via serum carotenoid measures.
  • To assess changes from baseline to 6 and 12 months in perceived benefit of dietary change, physical activity, and weight loss after a cancer diagnosis.
  • To measure changes from baseline in metabolic and hormonal biomarkers associated with breast and colorectal cancer recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin) at 6 and 12 months.
  • To assess changes from baseline in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function using the PROMISE-43 at 6 and 12 months.
  • To assess baseline predictors (medical history, health behaviors, quality of life) of subjects who adhere to and complete the intervention.
  • To assess the diversity of subjects who enroll and complete the intervention.
  • To assess the availability and acceptability of the Curves fitness centers at 12 months.
  • To explore changes in DNA methylation.
  • To assess the intervention and study process via open-ended interviews with SWOG sites and Curves franchises.
  • To measure changes in anthropometric measures and assess feasibility of extended follow-up at 24 and 36 months.
  • To assess the safety of the Curves® fitness centers for this population by assessing self-reported changes in lymphedema and any injuries as measured at 6 and 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
— 至 120 Years(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Attendance of ≥ 2 Curves sessions/week for a minimum of 36 of the 52 weeks of intervention

时间窗: 1 year from registration

Increase in fruit and vegetable consumption by 1 full serving per day (not including iceberg lettuce, potatoes, or fruit juices) OR reduce caloric intake by 100 kcal/day

时间窗: 1 year from registration

次要结局

  • Changes in anthropometric measures (weight, BMI, waist circumference, hip circumference)(1 year from registration)
  • Changes in body composition (% body fat as assessed by DXA scan at 12 months only)(1 year from registration)
  • Changes in dietary intake patterns based on three separate 24-hour diet recalls(1 year from registration)
  • Changes in minutes spent per week in moderate-to-vigorous intensity aerobic activity using Curves attendance records and a 7-day physical activity recall assessment(1 year from registration)
  • Changes in metabolic and hormonal biomarkers associated with breast and colorectal cancer-recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin)(3 years)
  • Changes in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function as measured by the PROMIS-43(1 year from registration)
  • DNA methylation patterns(3 years)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (115)

Loading locations...

相似试验